BIOMERIEUX 28/05/2026 AGM
1Approve Financial StatementsFor
2Approve Consolidated Financial StatementsFor
3Discharge the BoardFor
4Approve the Dividend of EUR 0.98 Per ShareFor
5Approve Transaction With Merieux Group Entities and Fondation Merieux Re: Employee Mobility Management For
6Approve Transaction With Fonds De Dotation Biomerieux Re: Philanthropy Agreement For
7Approve Transaction With Fonds De Dotation Biomerieux Re: "We Act for the Children" Philanthropy Agreement For
8Elect Alexandre Mérieux - Chair (Executive)Oppose
9Elect François Lacoste - Non-Executive DirectorOppose
10Elect Jean-Luc Bélingard - Non-Executive DirectorOppose
11Approve Remuneration of Directors in the Aggregate Amount of EUR 700,000 For
12Approve Remuneration PolicyOppose
13Approve Remuneration Policy of Chairman of the Board Oppose
14Approve Remuneration Policy of CEO Oppose
15Approve Remuneration Policy of Directors For
16Approve Compensation Report of Corporate Officers Oppose
17Approve Compensation of Alexandre Merieux, Chairman of the Board Oppose
18Approve Compensation of Pierre Boulud, CEO Oppose
19Approve Amended Share Purchase Program (Myshare 2026) Reserved for Beneficiaries Employed in the State of California, USA For
20Authorise Share RepurchaseFor
21Authorise Cancellation of Treasury SharesFor
22Issue Shares with Pre-emption Rights for Use in Employee Stock Purchase Plans For
23Issue Shares for Cash for Use in Employee Stock Purchase Plans For
24Authorize Up to 10 Percent of Issued Capital for Use in Stock Option Plans For
25Set Total Limit for Capital Increase to Result From All Issuance Requests Under Item 22 at EUR 4,210,280 For
26Amend Articles: Board Composition, Employee Shareholder Representation and Board Decision-Making ProceduresFor
27Authorize Filing of Required Documents/Other Formalities For